Revenue

9 Months Ended

Sep. 30, 2020

Revenue Recognition [Abstract]

Revenue

3.  Revenue

Net sales by geography are as follows (in millions):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Americas	$	1,216.5	$	1,179.2	$	3,051.5	$	3,587.6
EMEA		366.2		374.6		983.0		1,276.5
Asia Pacific		346.6		338.6		904.7		992.4
Total	$	1,929.3	$	1,892.4	$	4,939.2	$	5,856.5

Net sales by product category are as follows (in millions):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Knees	$	648.7	$	651.9	$	1,652.7	$	2,049.5
Hips		484.1		459.2		1,246.4		1,421.1
S.E.T.		359.9		348.5		946.1		1,062.3
Dental, Spine & CMFT		295.5		275.5		729.7		855.2
Other		141.1		157.3		364.3		468.4
Total	$	1,929.3	$	1,892.4	$	4,939.2	$	5,856.5

In the first quarter of 2020, we updated our product category revenue reporting format to further align with our announced reorganization.  Product category sales include the following changes:

• Surgical products, previously reported in the S.E.T. (Sports Medicine, Extremities and Trauma) product category, are included in the Other product category;

• Dental products are combined with Spine and CMF (Craniomaxillofacial) products into one product category;

• The CMF product category name has been changed to CMFT (Craniomaxillofacial and Thoracic), to reflect the Thoracic business, which is included in that category; and

• Other immaterial adjustments related to brand alignment within product categories in the Asia Pacific region have been made.

Prior period product category sales have been reclassified to conform to the current presentation.